Research & Development



  太宰听得很清楚,連忙扛著竹梯跑了過去,在灰塵中找不到雲瑯的所在,著急的大喊大叫。   太宰見雲瑯安靜了,這才松開手,剛剛松開,就听雲瑯用顫抖的聲音道︰“蛇,好大的蛇!”超碰新免费视频公开 超碰免费视频97   在劉徹之前,在大漢國,誰都可以鑄錢,只要你手里有銅,有工匠就能造錢,這是一門利潤豐厚的行當。   曹襄撇撇嘴並不在乎,他回首瞅著山下的長門宮,越想越覺得自己的法子很可行……青娱乐视频   然後就把這個半夜不睡覺喜歡拿著蠟燭亂跑的混蛋推出了大門。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo